UBS Maintains Buy on DaVita, Raises Price Target to $235

Benzinga Newsdesk www.benzinga.com Positive 80.3%

Neg 0% Neu 0% Pos 80.3%

UBS analyst A.J. Rice maintains DaVita (NYSE:DVA) with a Buy and raises the price target from $190 to $235.

Comments

No comments yet. Be the first!